8-K: Venus Concept Reports Fiscal Year 2023 Results, Achieves 50% Cash Burn Reduction

Venus Concept announced its fiscal year 2023 results, highlighting a significant reduction in cash burn and strategic restructuring efforts despite a decrease in overall revenue.

Summary

• Venus Concept reported a 23% decrease in total revenue for fiscal year 2023, reaching $76.4 million, down from $99.5 million in the previous year.
• The company successfully reduced its cash burn by 52% year-over-year, with cash used in operations totaling $12.9 million in 2023 compared to $27.0 million in 2022.
• Operating expenses decreased by 20% year-over-year to $19.7 million, including $0.3 million in restructuring costs.
• The net loss attributable to stockholders was $37.3 million for the year, a 15% improvement compared to the $43.7 million loss in the prior year.
• Adjusted EBITDA loss for the year was $20.3 million, a 20% improvement from the $25.4 million loss in the previous year.
• Cash system revenue represented 67% of total systems and subscriptions revenue in 2023, up from 58% in 2022.
• The company's international revenue decreased by 31% and US revenue decreased by 17% for the year.
• For the fourth quarter of 2023, total revenue was $18.1 million, a 25% decrease year-over-year, but a 3% increase quarter-over-quarter.
• The company expects total revenue for the three months ending March 31, 2024 to be at least $16.5 million.

Sentiment

Score: 4

Explanation: The document presents a mixed picture. While the company has made progress in reducing cash burn and operating expenses, the significant revenue decline and ongoing strategic review create uncertainty. The company is also facing challenges in regaining compliance with Nasdaq listing rules. The sentiment is therefore cautiously negative.

Positives

• The company successfully reduced cash burn by over 50% year-over-year.
• Operating expenses decreased by 20% year-over-year, indicating effective cost management.
• The company improved its gross margin in the fourth quarter of 2023.
• The company restructured its debt obligations, improving its financial position.
• The company launched a new product, Venus Versa Pro, in the US market.
• The company is actively exploring strategic alternatives to enhance shareholder value.
• The company secured continued listing on the Nasdaq Capital Market, subject to certain conditions.

Negatives

• Total revenue decreased by 23% for the full year and 25% in the fourth quarter year-over-year.
• International revenue saw a significant decrease of 31% for the year and 40% in the fourth quarter year-over-year.
• The company experienced a net loss of $37.3 million for the year and $11.1 million for the fourth quarter.
• System sales were softer than expected due to macroeconomic headwinds and restructuring in international markets.
• The percentage of total systems revenue derived from the subscription model decreased to 29% for the year, compared to 42% in the prior year.

Risks

• Macroeconomic headwinds and tighter credit markets are impacting system sales.
• The company's restructuring activities in international markets have negatively affected revenue.
• The company is facing challenges in regaining compliance with Nasdaq listing rules.
• The company has a significant debt load of approximately $74.9 million.
• The company is not providing full year 2024 financial guidance at this time, indicating uncertainty.

Future Outlook

The company expects total revenue for the three months ending March 31, 2024 to be at least $16.5 million. The company is not providing full year 2024 financial guidance at this time due to ongoing discussions with lenders and investors and the evaluation of strategic alternatives.

Management Comments

• Our fourth quarter revenue results reflect softer-than-expected system sales in the U.S. due to macroeconomic conditions and tighter credit markets, and by the impact of our accelerated restructuring activities in certain international markets, said Rajiv De Silva, Chief Executive Officer of Venus Concept.
• We have successfully executed our strategic turnaround plan, and our efforts to reposition and restructure the business resulted in a 20% reduction in operating expenses.
• Importantly, we delivered on our primary objective for 2023 to reduce cash burn by 50% or more year over year.
• We remain in active dialogue with our lenders and investors to find ways to best enable Venus Concept to achieve our strategic objectives and to accelerate the path to long-term, sustainable, profitability and growth.
• We also continue to explore strategic alternatives with various interested parties to maximize shareholder value.

Industry Context

The medical aesthetics industry is competitive, and Venus Concept's results reflect challenges faced by companies in this sector, including macroeconomic pressures and the need for strategic restructuring. The company's focus on reducing cash burn and exploring strategic alternatives is a common response to these challenges.

Comparison to Industry Standards

• While Venus Concept has shown progress in reducing cash burn and operating expenses, its revenue decline of 23% for the year is significant and worse than some competitors in the medical aesthetics space.
• Companies like InMode and Cutera have shown stronger revenue growth in recent periods, although they may have different product mixes and geographic focuses.
• InMode reported a 20% increase in revenue for 2023, while Cutera reported a 10% increase in revenue for 2023, highlighting the challenges Venus Concept faces in the current market.
• Venus Concept's focus on subscription-based revenue is a trend in the industry, but the decrease in the percentage of total systems revenue derived from the subscription model is a concern.
• The company's debt restructuring is similar to actions taken by other companies facing financial challenges, but the long-term impact remains to be seen.

Stakeholder Impact

• Shareholders are impacted by the decrease in revenue and the ongoing strategic review, which creates uncertainty about the company's future.
• Employees may be affected by the restructuring activities and potential changes in the company's direction.
• Customers may experience changes in product availability and support due to the company's restructuring efforts.
• Suppliers and creditors are impacted by the company's financial challenges and debt restructuring.

Next Steps

• The company will continue to evaluate strategic alternatives to maximize shareholder value.
• The company must demonstrate compliance with Nasdaq Listing Rule 5550(b) on or before May 28, 2024.
• The company will continue to engage with lenders and investors to secure its financial position.
• The company will host a conference call on April 1, 2024 to discuss the results.

Key Dates

Keywords

Venus Concept, Medical Aesthetics, Financial Results, Cash Burn, Restructuring, Revenue, EBITDA, Debt Restructuring, Nasdaq, Venus Versa Pro